Dear Guest,

We hope you're having a lovely Summer so far! As always, there is a lot to report from NDPL and the world of stem cells. In this newsletter you'll learn about a potential game-changer in the treatment of type 1 Diabetes, our new NDPL research paper library, and last but not least, our laboratory's appearance on Lifetime TV!

   
Viacyte's PEC-Direct Implant
Implants derived from stem cells are potential game-changer in treating type 1 Diabetes    

Earlier this month, San Diego-based ViaCyte announced that was conducting human tests using an islet-cell replacement candidate product for patients with type 1 diabetes. The product, PEC-Direct, produces pancreatic progenitor cells that can replace damaged or missing pancreatic cells. 

FShare this

Tweet this

   
New NDPL Research Library
New NDPL Dental Pulp Stem Cell Research Library

Recently, the NDPL Research Paper Library has had few additions…and also a makeover! If you are looking for a complete, current source of the latest DPSC research publications, we encourage you to visit our newly revamped library!
   
Check out the NDPL Lab on Lifetime TV! 

 Did you happen to see the NDPL lab on Lifetime TV? As part of Cord Blood Awareness Month, our affiliate New England Cord Blood Bank was featured on ‘The Balancing Act’. In NECBB’s Cord Blood processing video segment, you’ll be taken into the NECBB/NDPL science lab to...